Mavin Records - Overdose ft Crayon, Ayra Starr, Ladipoe, Magixx, Boy Spyce | Download Video MP4
Posted By: Craft Party(Download and Watch on TrendyBeatz)
Download Mavin Records - Overdose ft Crayon, Ayra Starr, Ladipoe, Magixx, Boy Spyce
Artist Name: Mavin Records
featuring: Crayon ,Ayra,Starr ,Ladipoe ,Magixx ,Boy,Spyce
Track title: Overdose
Year of Release: 2022 Videos
Category: Latest Video
Country: Naija Music Video
Advertisement
Today, the Nigerian record label, Mavin offers the fans a new sweet melody titled "Overdose" featuring Crayon, Ayra Starr, Ladipoe, Magixx, and Boy Spyce.
With the production of the CEO, Don Jazzy, Mavin Records thrills the fans with a new beautiful song titled "Overdose" which features the signees, Crayon, Ayra Starr, Ladipoe, Magixx, and Boy Spyce. They released this song in the year, 2022 which has started going viral and becoming the new Afrobeat music to enjoy this time.
Mavin Records is a Nigerian music corporation record label founded by record producer and recording artist Don Jazzy on 8 May 2012. It is one of the best record labels in Nigeria and Africa which houses lots of recording artists and producers. in 2014, they won the "Best Record Label of the Year" At the City People Entertainment Awards.
After the success of their great hit song "Dorobucci" in 2014, the label CEO, Don Jazzy comes to the conclusion of releasing a new piece of music since the fans wanted one. It was produced by him and feature vocals from Crayon, Ayra Starr, Ladipoe, Magixx and the newly signed crooner, Boy Spyce. It is a nice record made of Afrobeat where the signees showcase their different capabilities and fans are delighted for such an offering this season. Trust me, you won't like to miss this one.
Listen and download the song below!!!
Advertisement
Trending on TrendyBeatz!!
And Also
Download Audio: Mavin Records Overdose (Video) ft Crayon, Ayra Starr, Ladipoe, Magixx, Boy Spyce Mp4
Share post on
META TAGS
Mavin Records Crayon, Ayra Starr, Ladipoe, Magixx, Boy Spyce Overdose
You May Also Like;
Comments (0)